Idioma:

Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram

White, Rebekah R ; Kattan, Michael W ; Haney, John C ; Clary, Bryan M ; Pappas, Theodore N ; Tyler, Douglas S ; Brennan, Murray F

Annals of surgical oncology, 2006-11, Vol.13 (11), p.1485-1492 [Periódico revisado por pares]

United States: Springer Nature B.V

Texto completo disponível

Citações Citado por

Enviar para

Título:
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram
Autor: White, Rebekah R ; Kattan, Michael W ; Haney, John C ; Clary, Bryan M ; Pappas, Theodore N ; Tyler, Douglas S ; Brennan, Murray F
Assuntos: Adenocarcinoma ; Adenocarcinoma - drug therapy ; Adenocarcinoma - radiotherapy ; Adenocarcinoma - surgery ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Biopsy ; Chemoradiotherapy ; Chemotherapy, Adjuvant ; Combined Modality Therapy ; Female ; Humans ; Lymph nodes ; Lymphatic system ; Male ; Middle Aged ; Nomograms ; Pancreatic cancer ; Pancreatic Neoplasms - drug therapy ; Pancreatic Neoplasms - radiotherapy ; Pancreatic Neoplasms - surgery ; Pancreatic Neoplasms - therapy ; Pancreaticoduodenectomy ; Patients ; Preoperative Care ; Prognosis ; Radiotherapy, Adjuvant ; Survival ; Tumors
É parte de: Annals of surgical oncology, 2006-11, Vol.13 (11), p.1485-1492
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Theoretical benefits of preoperative chemoradiation therapy (preop CRT) for pancreatic cancer include improved efficacy, resectability, and patient selection. The goal of this study was to evaluate the applicability of a nomogram, which was developed for patients undergoing resection without preop CRT and which incorporates several post-resection pathological factors, to a population of patients who received preop CRT prior to resection. From 1994 to 2004, 82 patients with biopsy-proven, radiographically localized adenocarcinoma of the pancreatic head underwent preop CRT followed by pancreaticoduodenectomy (PD); 50 concurrent patients underwent PD without preop CRT. Mean nomogram-predicted disease-specific survival (DSS) rates were compared with observed DSS rates from the time of resection. Despite having more locally advanced tumors on initial staging (21 vs. 8%; P < .05), patients who received preop CRT had smaller resected tumors (mean 2.3 vs. 3.1 cm; P < .01), were less likely to have T3 tumors (54 vs. 80%, P < .01), were less likely to have positive lymph nodes (29 vs. 58%, P < .01), and had fewer positive lymph nodes (mean .4 vs. 1.9, P < .01), all factors that imply treatment effect and favorably impact on nomogram-predicted DSS. Observed DSS was similar to predicted DSS in both groups. The similarity in observed and predicted DSS following resection in patients who received preop CRT suggests that the effects of preop CRT-whether treatment, selection, or no effect-are reflected by the nomogram. The ability of the nomogram to evaluate the effects of preop CRT on survival is limited by the potential effects of preop CRT on factors within the nomogram.
Editor: United States: Springer Nature B.V
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 7 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram

White, Rebekah R ; Kattan, Michael W ; Haney, John C ; Clary, Bryan M ; Pappas, Theodore N ; Tyler, Douglas S ; Brennan, Murray F

United States: Springer Nature B.V

Buscando em bases de dados remotas. Favor aguardar.